Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

IntroductionApproximately 30% of patients diagnosed with stage Ia-b NSCLC die of recurrent disease after surgery. This study aimed to identify immune-related biomarkers that might predict tumor recurrence in stage Ia-b NSCLC within 40 months after curative resection.MethodsGene expression data of st...

Full description

Bibliographic Details
Main Authors: Qiang Wang, Danting Zhou, Fang Wu, Qingchun Liang, Qiongzhi He, Muyun Peng, Tianyu Yao, Yan Hu, Banglun Qian, Jingqun Tang, Xiang Wang, Wenliang Liu, Fenglei Yu, Chen Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
lung cancer
recurrence
TILs (tumor-infiltrating lymphocytes)
gene expression
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.680287/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.680287/full

Similar Items